Compare Prudential Financial Inc (PRU) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Prudential Financial (PRU) trades at $112.36, down 1.04% with bearish technical signals despite recent earnings beats. The stock shows attractive valuation metrics with P/E of 10.29 and P/S of 0.61, while maintaining solid profitability with 6.04% net margin and 12.46% ROE. Recent strategic moves include exiting emerging markets with Alexforbes sale and rebranding to Prudential Wealth Advisors, reflecting focus on core operations.

While valuation appears compelling and higher interest rates benefit investment income, analyst sentiment remains cautious with 67.57% hold ratings. The stock faces execution risks from strategic restructuring and competitive pressures in insurance markets. Current price near consensus target of $105.67 suggests limited near-term upside despite fundamental strength.

Zimmer Biomet (ZBH) trades at $88.49, down 1.33% today, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.07 surpassing the $2.01 estimate. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated to 9.48%. A quarterly dividend of $0.24 was declared, payable in October 2026. Analyst consensus price target is $103.11, implying potential upside from current levels.

The outlook is mixed: solid fundamentals and earnings momentum support long-term value, but technical weakness and elevated debt levels pose near-term risks. Investment appeal hinges on execution of commercial transformation and robotics adoption offsetting competitive pressures. Key risks include margin compression and macroeconomic sensitivity affecting procedure volumes.